BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 32226333)

  • 1. Intravascular Large B-Cell Lymphoma: Clinical and Histopathologic Findings.
    Charifa A; Paulson N; Levy L; Perincheri S; Lee A; McNiff JM; Ko CJ
    Yale J Biol Med; 2020 Mar; 93(1):35-40. PubMed ID: 32226333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
    Chiappella A; Martelli M; Angelucci E; Brusamolino E; Evangelista A; Carella AM; Stelitano C; Rossi G; Balzarotti M; Merli F; Gaidano G; Pavone V; Rigacci L; Zaja F; D'Arco A; Cascavilla N; Russo E; Castellino A; Gotti M; Congiu AG; Cabras MG; Tucci A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U
    Lancet Oncol; 2017 Aug; 18(8):1076-1088. PubMed ID: 28668386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial.
    Shimada K; Yamaguchi M; Atsuta Y; Matsue K; Sato K; Kusumoto S; Nagai H; Takizawa J; Fukuhara N; Nagafuji K; Miyazaki K; Ohtsuka E; Okamoto M; Sugita Y; Uchida T; Kayukawa S; Wake A; Ennishi D; Kondo Y; Izumi T; Kin Y; Tsukasaki K; Hashimoto D; Yuge M; Yanagisawa A; Kuwatsuka Y; Shimada S; Masaki Y; Niitsu N; Kiyoi H; Suzuki R; Tokunaga T; Nakamura S; Kinoshita T
    Lancet Oncol; 2020 Apr; 21(4):593-602. PubMed ID: 32171071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary intravascular large B-cell lymphoma accompanying synchronous primary pulmonary adenocarcinoma and benign interstitial lesions.
    Satoh T; Arai E; Kayano H; Sakaguchi H; Takahashi N; Tsukasaki K; Yasuda M
    J Clin Exp Hematop; 2019 Sep; 59(3):140-144. PubMed ID: 31391407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pY-STAT3 and p53 expression predict outcome for poor prognosis diffuse large B-cell lymphoma treated with high dose chemotherapy and autologous stem cell transplantation.
    Stewart DA; Bahlis N; Mansoor A
    Leuk Lymphoma; 2009 Aug; 50(8):1276-82. PubMed ID: 19562614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is your diagnosis? Cutaneous B-cell lymphoma.
    Carlson SW; Aneja S; Honda K; Cooper KD
    Cutis; 2014 Nov; 94(5):217, quiz 249-51. PubMed ID: 25474456
    [No Abstract]   [Full Text] [Related]  

  • 7. Diffuse systemic large B-cell lymphoma with secondary skin involvement.
    Lloret-Ruiz C; Molés-Poveda P; Barrado-Solís N; Gimeno-Carpio E
    Actas Dermosifiliogr; 2015 Oct; 106(8):685-7. PubMed ID: 26092177
    [No Abstract]   [Full Text] [Related]  

  • 8. Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL-TAMO Study Group.
    Arranz R; Conde E; Grande C; Mateos MV; Gandarillas M; Albo C; Lahuerta JJ; Fernández-Rañada JM; Hernández MT; Alonso N; García Vela JA; Garzón S; Rodríguez J; Caballero D;
    Eur J Haematol; 2008 Mar; 80(3):227-35. PubMed ID: 18088400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of DA-EPOCH-R induction plus autologous transplant consolidation for double hit lymphoma.
    Chen AI; Leonard JT; Okada CY; Gay ND; Chansky K; Fan G; Dunlap JB; Raess PW; Braziel RM; Stentz A; Maziarz RT
    Leuk Lymphoma; 2018 Aug; 59(8):1884-1889. PubMed ID: 29199519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravascular large B-cell lymphoma diagnosed by FDG-PET/CT and endometrial biopsy.
    Takeoka Y; Inaba A; Fujitani Y; Kosaka S; Yamamura R; Senzaki H; Okamura T; Ohta K
    Rinsho Ketsueki; 2011 Nov; 52(11):1777-81. PubMed ID: 22185801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Definitive diagnosis of intravascular large B-cell lymphoma by random skin biopsy].
    Kotake T; Takamori H; Kuwayama M; Hattori H; Takeda M; Takagi K; Karasuno T
    Gan To Kagaku Ryoho; 2011 Aug; 38(8):1361-4. PubMed ID: 21829082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensification treatment based on early FDG-PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial.
    Pardal E; Coronado M; Martín A; Grande C; Marín-Niebla A; Panizo C; Bello JL; Conde E; Hernández MT; Arranz R; Bargay J; González-Barca E; Pérez-Ceballos E; Montes-Moreno S; Caballero MD
    Br J Haematol; 2014 Nov; 167(3):327-36. PubMed ID: 25066542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravascular large B-cell lymphoma: an important cause of fever of unknown origin].
    Masaki Y; Miki M; Sakai T; Sawaki T; Fukushima T; Umehara H
    Brain Nerve; 2011 May; 63(5):435-41. PubMed ID: 21515922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upfront double high-dose chemotherapy with DICEP followed by BEAM and autologous stem cell transplantation for poor-prognosis aggressive non-Hodgkin lymphoma.
    Stewart DA; Bahlis N; Valentine K; Balogh A; Savoie L; Morris DG; Jones A; Brown C; Russell JA
    Blood; 2006 Jun; 107(12):4623-7. PubMed ID: 16467197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravascular B-cell lymphoma: the role of skin biopsy.
    Barnett CR; Seo S; Husain S; Grossman ME
    Am J Dermatopathol; 2008 Jun; 30(3):295-9. PubMed ID: 18496438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intensive treatment of T-cell-rich B lymphoma].
    Azaceta G; Palomera L; Varo MJ; Soria J
    Sangre (Barc); 1998 Feb; 43(1):94-5. PubMed ID: 9577190
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary cutaneous intravascular large B-cell lymphoma treated with combination chemotherapy and complicated by rituximab-induced interstitial lung disease.
    Park GH; Kim CH; Chung WK; Won CH; Chang SE; Lee MW; Choi JH; Moon KC
    Acta Derm Venereol; 2010 May; 90(3):296-8. PubMed ID: 20526551
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravascular large B-cell lymphoma of the skin: typical clinical manifestations and a favourable response to rituximab-containing therapy.
    Feldmann R; Schierl M; Sittenthaler M; Jahn R; Wogritsch C; Cerroni L; Steiner A; Breier F
    Dermatology; 2009; 219(4):344-6. PubMed ID: 19590171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proposal of possible diagnostic strategy for intravascular large B-cell lymphoma--usefulness of biopsy from senile hemangioma].
    Ishida M; Yoshii M; Yoshida T; Okabe H
    Rinsho Byori; 2012 Mar; 60(3):201-5. PubMed ID: 22568081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrotic syndrome without kidney injury revealing intravascular large B cell lymphoma.
    Pothen L; Aydin S; Camboni A; Hainaut P
    BMJ Case Rep; 2019 Jun; 12(6):. PubMed ID: 31196971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.